PD-L1 anticorps (AA 19-239)
-
- Antigène Voir toutes PD-L1 Anticorps
- PD-L1 (CD274 (PD-L1))
-
Épitope
- AA 19-239
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp PD-L1 est non-conjugé
-
Application
- Western Blotting (WB)
- Attributs du produit
- Mouse anti human B7-H1
- Immunogène
- AA 19-239
- Clone
- MM0102-9E5
- Isotype
- IgG1
- Top Product
- Discover our top product PD-L1 Anticorps primaire
-
-
- Indications d'application
- Optimal dilutions should be determined by each laboratory for each application.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- 200 µL of PBS, pH 7.4
- Concentration
- 500 µg/mL
- Buffer
- Lyophilized from a solution containing PBS, pH 7.4
- Stock
- -20 °C
-
- Antigène
- PD-L1 (CD274 (PD-L1))
- Autre désignation
- B7-H1 (PD-L1 Produits)
- Synonymes
- anticorps B7-H, anticorps B7H1, anticorps PD-L1, anticorps PDCD1L1, anticorps PDCD1LG1, anticorps PDL1, anticorps A530045L16Rik, anticorps B7h1, anticorps Pdcd1l1, anticorps Pdcd1lg1, anticorps Pdl1, anticorps RGD1566211, anticorps CD274 molecule, anticorps CD274 antigen, anticorps programmed cell death 1 ligand 2, anticorps CD274, anticorps Cd274, anticorps PDCD1LG2
- UniProt
- Q9NZQ7
- Pathways
- Cancer Immune Checkpoints
-